Δημοσιεύσεις
Δημοσιεύσεις
στο Pubmed
2010
|
TACC3-TSC2
maintains nuclear envelope structure and controls cell division.
Gómez-Baldó L., Schmidt S., Maxwell C.A., Bonifaci
N., Gabaldón T., Vidalain P-O., Senapedis W., Kletke A.,
Rosing M., Barnekow A., Rottapel R., Capellá G., Vidal M.,
Astrinidis A.§, Piekorz R.P.§, Pujana
M.A.§
§ αντεπιστέλλοντες συγγραφείς
Cell Cycle 9(6): 1143-1155
Σχολιάστηκε:
- TACCing on new functions for the TSC2 tumor suppressor.
Golemis E.A.
Cell Cycle 9(7): 1232-1233
- Interaction of TACC3 and TSC2 at the nuclear envelope and mitotic
structures.
Ertych N., Bastians H.
Cell Cycle 9(7): 1233
The
transcription factor SP1 regulates centriole function and chromosomal
stability through a functional interaction with the mammalian target
of rapamycin/raptor complex.
Astrinidis A., Kim J., Kelly C.M., Olofsson B.A., Torabi B., Sorokina
E.M., Azizkhan-Clifford J.
Genes Chromosomes Cancer 49(3): 282-297
|
2009
|
The
p53 target Plk2 interacts with TSC proteins impacting mTOR signaling,
tumor growth, and chemosensitivity under hypoxic conditions.
Matthew E.M., Hart L.S., Astrinidis A., Navaraj A., Dolloff N.G.,
Dicker D.T., Henske E.P., El-Deiry W.S.
Cell Cycle 8(24): 4168-76
Estrogen
promotes the survival and pulmonary metastasis of tuberin-null cells.
Yu J.J., Robb V.A., Morrison T.A., Ariazi E.A., Karbowniczek M.,
Astrinidis A., Wang C., Hernandez-Cuebas L., Seeholzer L.F., Nicolas
E., Hensley H., Jordan V.C., Walker C.L., Henske E.P.
Proceedings of the National Academy of Sciences USA 106(8):
2345-40
|
2006
|
Mutation
detection in tumor suppressor genes using archival tissue specimens.
Astrinidis A. and Henske E.P.
Methods Molecular Medicine 126:
185-196 (Congenital Heart Disease: Molecular Diagnistics, M. Kearns-Jonker
ed.)
Frequent
hyperphosphorylation of ribosomal protein S6 in lymphangioleiomyomatosis-associated
angiomyolipomas. (2006)
Robb V.A., Astrinidis A., Henske E.P.
Modern Pathology 19(6): 839-46
Hamartin,
the tuberous sclerosis complex 1 gene product, interacts with polo-like
kinase 1 in a phosphorylation-dependent mannter. (2006)
Astrinidis A., Senapedis W., Henske E.P.
Human Molecular Genetics 15(2):
287-97
|
2005
|
Tuberous
sclerosis complex: linking growth and energy signaling pathways
with human disease. (2005)
Astrinidis A. and Henske E.P.
Oncogene 24(50):
7475-81. Review.
|
2004
|
Aberrant
cellular differentiation and migration in renal and pulmonary tuberous
sclerosis complex.
Astrinidis A. and Henske E.P.
Journal of Child Neurology 19(9):
710-5. Review.
Regulation
of B-Raf kinase activity by tuberin and Rheb is mTOR independent.
Karbowniczek M., Cash T., Cheung M., Robertson G.P., Astrinidis
A., Henske E.P.
Journal of Biological Chemistry 279(29):
29930-37
|
2003
|
Cell
cycle-regulated phosphorylation of hamartin, the product of the
tuberous sclerosis complex 1 gene, by CDK1/cyclin B.
Astrinidis A., Senapedis W., Coleman T.R., Henske E.P.
Journal of Biological Chemistry 278(51):
51372-79
Estradiol
and tamoxifen stimulate lymphangiomyomatosis-associated angiomyolipoma
cell growth and activate both genomic and non-genomic signaling
pathways. (2004)
Yu J.J., Astrinidis A., Howard S., Henske E.P.
American Journal of Physiology - Lung Cell Molecular Physiology
286(4): L694-700
|
2002
|
Tuberin,
the Tuberous Sclerosis 2 tumor suppressor gene product, regulates
Rho activation, cell adhesion, and cell migration. (2002)
Astrinidis A., Cash T., Hunter D., Walker C., Chernoff J., Henske
E.P.
Oncogene 21(55):
8470-6
Recurrent
lymphangiomyomatosis after transplantation: genetic analyses reveal
a metastatic mechanism.
Karbowniczek M., Astrinidis A., Balsara B.R., Testa J.R., Lium
J.H., Colby T.V., McCormack F.X., Henske E.P.
American Journal of Respiratory and Critical Care Medicine
167(7): 976-82
Expression
of wild type and mutant TSC2, but not TSC1, causes an increase in
the G1 fraction of the cell cycle in HEK293 cells.
Khare L., Astrinidis A., Senapedis W., Adams P.D., Henske E.P.
Journal of Medical Genetics 39(9):
676-80
|
2001
|
Chromosome
16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
Yu J.J., Astrinidis A., Henske E.P.
American Journal of Respiratory and Critical Care Medicine
164(8 Pt 1): 1537-40
|
2000
|
Mutations
in the tuberous sclerosis complex gene TSC2 are a cause of sporadic
pulmonary lymphangioleiomyomatosis.
Carsillo T., Astrinidis A., Henske E.P.
Proceedings of the National Academy of Sciences USA 97(11):
6085-90
Mutational
analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary
lymphangioleiomyomatosis.
Astrinidis A., Khare L., Carsillo T., Smolarek T., Au K.S., Northrup
H., Henske E.P.
Journal of Medical Genetics 37(1):
55-7
|
1999
|
Heterogeneity
of four beta-thalassaemia mutations in Greece.
Valianou M.G., Kouvatsi A., Hassapopoulou-Matamis H., Astrinidis
A., Triantaphyllidis C.
Hemoglobin 23(1):
79-82
Mitochondrial
DNA polymorphism in the Vietnamese population.
Ivanova R., Astrinidis A., Lepage V., Djoulah S., Wijnen E., Vu-Trieu
A.N., Hors J., Charron D.
European Journal of Immunogenetics 26(6):
417-422
Mitochondrial
DNA polymorphisms of a west Algerian population (Oran region).
Ivanova R., Astrinidis A., Djoulah S., Lepage V., Wijnen E., Hors
J., Charron D.
Biomedical Pharmacotherapy 53(8):
386-92
Mitochondrial
DNA polymorphism in the French population.
Ivanova R., Astrinidis A., Lepage V., Kouvatsi A., Djoulah S., Hors
J., Charron D.
Biomedical Pharmacotherapy 53(4):
207-12
Mitochondrial DNA polymorphism in the Bulgarian population.
Ivanova R., Astrinidis A., Lepage V., Wijnen E., Naumova E., Charron
D.
Balkan Journal of Medical Genetics 2:
9-16
|
1998
|
Novel
intragenic polymorphisms in the tuberous sclerosis 2 (TSC2) gene.
Astrinidis A.§, Kouvatsi A., Nahmias J., Povey S., Pandeliadis
C., Danzaki A.,Schneider M., Triantaphyllidis C.
§ αντεπιστέλλων συγγραφέας
Human Mutation 12:
217 (abstract) / on line mutation in brief #184
Μοριακή Μελέτη της Οζώδους Σκλήρυνσης.
Αστρεινίδης Α.
Διδακτορική Διατριβή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, Θεσσαλονίκη,
Ελλάδα
|
1994
|
Mitochondrial
DNA polymorphisms in Northern Greece.
Astrinidis A. and Kouvatsi A.
Human Biology 66(4):
601-611
|
|